Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Bio Essence (BIOE) over the last 6 years, with Q3 2025 value amounting to $38.0 million.

  • Bio Essence's Shares Outstanding (Weighted Average) changed 0.0% to $38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $38.0 million for FY2024, which is 1194.2% up from last year.
  • According to the latest figures from Q3 2025, Bio Essence's Shares Outstanding (Weighted Average) is $38.0 million, which was down 0.0% from $38.0 million recorded in Q2 2025.
  • In the past 5 years, Bio Essence's Shares Outstanding (Weighted Average) registered a high of $38.0 million during Q3 2023, and its lowest value of $33.0 million during Q1 2021.
  • Over the past 5 years, Bio Essence's median Shares Outstanding (Weighted Average) value was $34.0 million (recorded in 2023), while the average stood at $35.3 million.
  • In the last 5 years, Bio Essence's Shares Outstanding (Weighted Average) fell by 23.25% in 2021 and then surged by 1514.74% in 2023.
  • Quarter analysis of 5 years shows Bio Essence's Shares Outstanding (Weighted Average) stood at $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022, then increased by 2.86% to $34.0 million in 2023, then rose by 11.94% to $38.0 million in 2024, then changed by 0.0% to $38.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $38.0 million in Q3 2025, compared to $38.0 million in Q2 2025 and $38.0 million in Q1 2025.